The Human Host-Defense Peptide Cathelicidin LL-37 is a Nanomolar Inhibitor of Amyloid Self-Assembly of Islet Amyloid Polypeptide (IAPP)

Keyphrases

• Anti-amyloidogenic 25%
• Antimicrobial 50%
• Cathelicidin 25%
• Cathelicidin LL-37 100%
• Cell Damage 25%
• Cell Degeneration 25%
• Derived Peptide 25%
• Diabetes Pathogenesis 25%
• Host Defense Peptides 100%
• Human Cathelicidin LL-37 25%
• Human Host 100%
• Human Islet Amyloid Polypeptide (hIAPP) 100%
• Immunomodulatory 50%
• Inflammation 25%
• Inflammation Cells 25%
• LL-37 75%
• Multifunctional Drugs 25%
• Multifunctional Hosts 25%
• Pancreatic Cells 25%
• Pancreatic Inflammation 25%
• Polypeptide 25%
• Protective Behavior 25%
• Self-assembly 100%
• Type 2 Diabetes Mellitus (T2DM) 75%

Medicine and Dentistry

• Acute Pancreatitis 25%
• Amylin 100%
• Amyloid Protein 100%
• Antiinfective Agent 50%
• Cathelicidin 25%
• Cathelicidin Antimicrobial Peptide LL 37 100%
• Cell Damage 25%
• Cell Degeneration 25%
• Host Resistance 100%
• In Vitro 25%
• Maturity Onset Diabetes of the Young 75%
• Pancreatitis 25%
• Polypeptide 25%

Biochemistry, Genetics and Molecular Biology

• Amylin 100%
• Amyloid Protein 100%
• Cathelicidin 100%
• Cell Damage 25%
• Cell Degeneration 25%
• Host Resistance 100%